Skip to main content
Log in

NICE not recommending evolocumab for high cholesterol

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. cardiovascular disease events

Reference

  • NICE. NICE issues draft guidance on evolocumab for lipid disorder. Media Release : 18 Nov 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE not recommending evolocumab for high cholesterol. PharmacoEcon Outcomes News 742, 36 (2015). https://doi.org/10.1007/s40274-015-2664-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2664-y

Navigation